Introdução: A Doença do refluxo gastroesofágico (DRGE) é uma das desordens mais comuns da prática clínica. Dados americanos indicam que pirose, o sintoma mais predominante desta condição, ocorre pelo menos uma vez por semana em até 20% da população estudada. A etiologia da DRGE é multifatorial, mas a incompetência da junção esofagogástrica (JEG) tem importância crucial. Alguns parâmetros manométricos já estabelecidos para avaliação da função de barreira anti-refluxo da JEG apresentam eficácia insuficiente, provavelmente porque refletem apenas um breve e, não necessariamente representativo, período de aquisição (até 30 segundos). Este estudo testou a habilidade de novos métodos para avaliação funcional da JEG, através da manometria de alta resolução (MAR), para avaliação do padrão de refluxo avaliado por monitorização prolongada do pH. Métodos: Estudo multicêntrico internacional, onde 517 participantes foram submetidos à MAR associada ou não à monitorização prolongada do pH para estudo da função de barreira anti-refluxo da JEG. A morfologia da JEG, classificada através de seus três subtipos (tipo I, onde EIE e CD estão interpostos; tipo II, onde há separação entre EIE e CD de até 2 cm; e tipo III, com separação entre EIE e CD superior a 2 cm), pressão integrada do esfíncter inferior do esôfago (PI-EIE) e índice de contratilidade da junção esofagogástrica (IC-JEG) foram comparados com o índice de contratilidade da junção esofagogástrica total (IC-JEG Total), um novo parâmetro que sumariza a função de barreira da JEG durante todo o protocolo da MAR. Foi considerada anormal exposição ácida esofágica >= 4.2 % / 24 h (grupo pH-Reflux-pat), enquanto pacientes sem exposição ácida anormal compuseram o grupo pH-Reflux-fis. Resultados: 65 voluntários sadios e 452 pacientes completaram a MAR. Trezentos e oitenta (84%) dos pacientes foram submetidos à monitorização prolongada do pH. PI-EIE, IC-JEG, IC-JEG Total se correlacionaram com os subtipos morfológicos da JEG (todos p <.00001). Somente o IC-JEG Total foi consistentemente mais baixo nos pacientes pH-Reflux-pat comparados com os voluntários sadios e os pacientes do grupo pH-Reflux-fis. IC-JEG Total também foi o parâmetro isolado com melhor capacidade de predizer refluxo anormal (ponto de corte ótimo 77 mmHg·cm, AUC 0.645, p < .0001). Esse valor de ponto de corte apresentou sensibilidade de 86% e valor preditivo positivo de 57%, com especificidade de 39% e valor preditivo negativo de 74% para o diagnóstico de DRGE. Conclusão: Parâmetros da MAR que avaliam a contratilidade da JEG são capazes de distinguir pacientes com e sem exposição ácida patológica e voluntários sadios. IC-JEG Total permite um aprimoramento da avaliação da função de barreira da JEG / Background: Gastroesophageal reflux disease (GERD) is one of the most common disorders in medical practice. Data from North America indicate that heartburn, the most predominant symptom of the disorder, occurs at least once a week in 20% of the studied population. Etiology of GERD is multifactorial, but incompetence of the esophagogastric junction (EGJ) appears to be of crucial importance. Established manometric parameters for assessment of EGJ barrier function are sub-optimal, potentially because they reflect only a very brief (up to 30 seconds), not necessarily representative period. This study tested the performance of novel, high-resolution manometry (HRM) parameters of EGJ function in the assessment of GERD. Methods: Patients with reflux symptoms and healthy controls (HC) underwent standard HRM associated or not with 24-hour pH monitoring. EGJ morphology, classified in three subtypes (type I, with complete overlap of the CD and the LES; type II, with minimal LES-CD separation; and type III, with LES-CD separation greater than 2 centimeters), lower esophageal sphincter pressure integral (LES-PI) and EGJ contractile integral (EGJ-CI) were compared with total-EGJ-CI, a novel parameter summarizing EGJ barrier function during the entire HRM protocol. Esophageal acid exposure >= 4.2%/24 h (pH-Reflux-pat) were considered pathological. Key Results: Sixty five HC and 452 patients completed HRM, 380 (84%) patients underwent ambulatory reflux-monitoring. LES-PI, EGJ-CI and total- EGJ- CI correlated with EGJ morphology subtypes (all p < .00001). Only total-EGJCI was consistently lower in pH-Reflux-pat subjects compared with HC and patients without GERD. Total-EGJ-CI was also the single best parameter for prediction of pathological reflux (optimal cut-off 77 mmHg·cm, AUC 0.645, P <.0001). This cutoff value showed good sensitivity 86% and positive predictive value 57%, modest specificity 39% and good negative predictive value 74% for GERD diagnosis based on pH-monitoring. Conclusion: Novel HRM parameters of EGJ function are efficient in identifying patients with and without pathological acid exposure and HC. Total EGJ-CI, a new metric that summarizes EGJ contractility over time, allows an improved assessment of EGJ barrier function

Introdução: A colocação de próteses através da junção esofagogástrica propicia o refluxo gastroesofágico. Objetivos e métodos: Avaliação da paliação da disfagia, manifestações broncoaspirativas, parâmetros nutricionais e qualidade de vida de 30 pacientes com tumores avançados da junção esofagogástrica tratados por prótese metálica auto-expansível com válvula anti-refluxo de 2001 a 2004. Resultados: Melhora da disfagia e regurgitação. Sem alteração na tosse, eructação, pirose, parâmetros nutricionais e qualidade de vida. Conclusões: A prótese com válvula anti-refluxo foi eficaz na paliação da disfagia, impediu a ocorrência de manifestações broncoaspirativas, não interferiu nos parâmetros nutricionais e qualidade de vida / Background: Placement of stents through the gastroesophageal junction can cause reflux. Objective and methods: Evaluate dysphagia palliation, aspiration symptoms, nutritional parameters and quality of life in 30 patients treated for advanced gastroesophageal junction tumors with a self-expanding metal stent with anti-reflux valve from 2001 to 2004. Results: Dysphagia and regurgitation symptoms improved after placement. There was no changes in heartburn, cough, belching symptoms and also no improvement in nutritional parameters or quality of life. Conclusions: Antireflux valve self-expanding stents was effective in dysphagia palliation, avoided aspiration symptoms and did not affect nutritional parameters or quality of life

Gastric and esophagogastric junction cancers are heterogeneous and aggressive tumors with an unpredictable response to cytotoxic treatment. New methods allowing for the analysis of drug resistance are needed. Here, we describe a novel technique by which human tumor specimens can be cultured ex vivo, preserving parts of the natural cancer microenvironment. Using a tissue chop- per, fresh surgical tissue samples were cut in 400 μm slices and cultivated in 6-well plates for up to 6 days. The slices were processed for routine histopa- thology and immunohistochemistry. Cytokeratin stains (CK8, AE1/3) were ap- plied for determining tumor cellularity, Ki-67 for proliferation, and cleaved caspase-3 staining for apoptosis. The slices were analyzed under naive conditions and following 2–4 days in vitro exposure to 5-FU and cisplatin. The slice culture technology allowed for a good preservation of tissue morphology and tumor cell integrity during the culture period. After chemotherapy exposure, a loss of tumor cellularity and an increase in apoptosis were observed. Drug sensitivity of the tumors could be assessed. Organotypic slice cultures of gastric and es- ophagogastric junction cancers were successfully established. Cytotoxic drug effects could be monitored. They may be used to examine mechanisms of drug resistance in human tissue and may provide a unique and powerful ex vivo platform for the prediction of treatment response.

Contexte & Objectifs : La manométrie perfusée conventionnelle et la manométrie haute résolution (HRM) ont permis le développement d’une variété de paramètres pour mieux comprendre la motilité de l'œsophage et quantifier les caractéristiques de la jonction œsophago-gastrique (JOG). Cependant, l'anatomie de la JOG est complexe et les enregistrements de manométrie détectent à la fois la pression des structures intrinsèques et des structures extrinsèques à l'œsophage. Ces différents composants ont des rôles distincts au niveau de la JOG. Les pressions dominantes ainsi détectées au niveau de la JOG sont attribuables au sphincter œsophagien inférieur (SOI) et aux piliers du diaphragme (CD), mais aucune des technologies manométriques actuelles n’est capable de distinguer ces différents composants de la JOG. Lorsqu’on analyse les caractéristiques de la JOG au repos, celle ci se comporte avant tout comme une barrière antireflux. Les paramètres manométriques les plus couramment utilisés dans ce but sont la longueur de la JOG et le point d’inversion respiratoire (RIP), défini comme le lieu où le pic de la courbe de pression inspiratoire change de positif (dans l’abdomen) à négatif (dans le thorax), lors de la classique manœuvre de « pull-through ». Cependant, l'importance de ces mesures reste marginale comme en témoigne une récente prise de position de l’American Gastroenterology Association Institute (AGAI) (1) qui concluait que « le rôle actuel de la manométrie dans le reflux gastro-œsophagien (RGO) est d'exclure les troubles moteurs comme cause des symptômes présentés par la patient ». Lors de la déglutition, la mesure objective de la relaxation de la JOG est la pression de relaxation intégrée (IRP), qui permet de faire la distinction entre une relaxation normale et une relaxation anormale de la JOG. Toutefois, puisque la HRM utilise des pressions moyennes à chaque niveau de capteurs, certaines études de manométrie laissent suggérer qu’il existe une zone de haute pression persistante au niveau de la JOG même si un transit est mis en évidence en vidéofluoroscopie. Récemment, la manométrie haute résolution « 3D » (3D-HRM) a été développée (Given Imaging, Duluth, GA) avec le potentiel de simplifier l'évaluation de la morphologie et de la physiologie de la JOG. Le segment « 3D » de ce cathéter de HRM permet l'enregistrement de la pression à la fois de façon axiale et radiale tout en maintenant une position fixe de la sonde, et évitant ainsi la manœuvre de « pull-through ». Par conséquent, la 3D-HRM devrait permettre la mesure de paramètres importants de la JOG tels que sa longueur et le RIP. Les données extraites de l'enregistrement fait par 3D-HRM permettraient également de différencier les signaux de pression attribuables au SOI des éléments qui l’entourent. De plus, l’enregistrement des pressions de façon radiaire permettrait d’enregistrer la pression minimale de chaque niveau de capteurs et devrait corriger cette zone de haute pression parfois persistante lors la déglutition. Ainsi, les objectifs de ce travail étaient: 1) de décrire la morphologie de la JOG au repos en tant que barrière antireflux, en comparant les mesures effectuées avec la 3D-HRM en temps réel, par rapport à celle simulées lors d’une manœuvre de « pull-through » et de déterminer quelles sont les signatures des pressions attribuables au SOI et au diaphragme; 2) d’évaluer la relaxation de la JOG pendant la déglutition en testant l'hypothèse selon laquelle la 3D-HRM permet le développement d’un nouveau paradigme (appelé « 3D eSleeve ») pour le calcul de l’IRP, fondé sur l’utilisation de la pression radiale minimale à chaque niveau de capteur de pression le long de la JOG. Ce nouveau paradigme sera comparé à une étude de transit en vidéofluoroscopie pour évaluer le gradient de pression à travers la JOG. Méthodes : Nous avons utilisé un cathéter 3D-HRM, qui incorpore un segment dit « 3D » de 9 cm au sein d’un cathéter HRM par ailleurs standard. Le segment 3D est composé de 12 niveaux (espacés de 7.5mm) de 8 capteurs de pression disposés radialement, soit un total de 96 capteurs. Neuf volontaires ont été étudiés au repos, où des enregistrements ont été effectués en temps réel et pendant une manœuvre de « pull-through » du segment 3D (mobilisation successive du cathéter de 5 mm, pour que le segment 3D se déplace le long de la JOG). Les mesures de la longueur du SOI et la détermination du RIP ont été réalisées. La longueur de la JOG a été mesurée lors du « pull-through » en utilisant 4 capteurs du segment 3D dispersés radialement et les marges de la JOG ont été définies par une augmentation de la pression de 2 mmHg par rapport à la pression gastrique ou de l’œsophage. Pour le calcul en temps réel, les limites distale et proximale de la JOG ont été définies par une augmentation de pression circonférentielle de 2 mmHg par rapport à la pression de l'estomac. Le RIP a été déterminée, A) dans le mode de tracé conventionnel avec la méthode du « pull-through » [le RIP est la valeur moyenne de 4 mesures] et B) en position fixe, dans le mode de représentation topographique de la pression de l’œsophage, en utilisant l’outil logiciel pour déterminer le point d'inversion de la pression (PIP). Pour l'étude de la relaxation de la JOG lors de la déglutition, 25 volontaires ont été étudiés et ont subi 3 études de manométrie (10 déglutitions de 5ml d’eau) en position couchée avec un cathéter HRM standard et un cathéter 3D-HRM. Avec la 3D-HRM, l’analyse a été effectuée une fois avec le segment 3D et une fois avec une partie non 3D du cathéter (capteurs standard de HRM). Ainsi, pour chaque individu, l'IRP a été calculée de quatre façons: 1) avec la méthode conventionnelle en utilisant le cathéter HRM standard, 2) avec la méthode conventionnelle en utilisant le segment standard du cathéter 3D-HRM, 3) avec la méthode conventionnelle en utilisant le segment « 3D » du cathéter 3D-HRM, et 4) avec le nouveau paradigme (3D eSleeve) qui recueille la pression minimale de chaque niveau de capteurs (segment 3D). Quatorze autres sujets ont subi une vidéofluoroscopie simultanée à l’étude de manométrie avec le cathéter 3D-HRM. Les données de pression ont été exportés vers MATLAB ™ et quatre pressions ont été mesurées simultanément : 1) la pression du corps de l’œsophage, 2cm au-dessus de la JOG, 2) la pression intragastrique, 3) la pression radiale moyenne de la JOG (pression du eSleeve) et 4) la pression de la JOG en utilisant la pression minimale de chaque niveau de capteurs (pression du 3D eSleeve). Ces données ont permis de déterminer le temps permissif d'écoulement du bolus (FPT), caractérisé par la période au cours de laquelle un gradient de pression existe à travers la JOG (pression œsophagienne > pression de relaxation de la JOG > pression gastrique). La présence ou l'absence du bolus en vidéofluoroscopie et le FPT ont été codés avec des valeurs dichotomiques pour chaque période de 0,1 s. Nous avons alors calculé la sensibilité et la spécificité correspondant à la valeur du FPT pour la pression du eSleeve et pour la pression du 3D eSleeve, avec la vidéofluoroscopie pour référence. Résultats : Les enregistrements avec la 3D-HRM laissent suggérer que la longueur du sphincter évaluée avec la méthode du « pull-through » était grandement exagéré en incorporant dans la mesure du SOI les signaux de pression extrinsèques à l’œsophage, asymétriques et attribuables aux piliers du diaphragme et aux structures vasculaires. L’enregistrement en temps réel a permis de constater que les principaux constituants de la pression de la JOG au repos étaient attribuables au diaphragme. L’IRP calculé avec le nouveau paradigme 3D eSleeve était significativement inférieur à tous les autres calculs d'IRP avec une limite supérieure de la normale de 12 mmHg contre 17 mmHg pour l’IRP calculé avec la HRM standard. La sensibilité (0,78) et la spécificité (0,88) du 3D eSleeve étaient meilleurs que le eSleeve standard (0,55 et 0,85 respectivement) pour prédire le FPT par rapport à la vidéofluoroscopie. Discussion et conclusion : Nos observations suggèrent que la 3D-HRM permet l'enregistrement en temps réel des attributs de la JOG, facilitant l'analyse des constituants responsables de sa fonction au repos en tant que barrière antireflux. La résolution spatiale axiale et radiale du segment « 3D » pourrait permettre de poursuivre cette étude pour quantifier les signaux de pression de la JOG attribuable au SOI et aux structures extrinsèques (diaphragme et artéfacts vasculaires). Ces attributs du cathéter 3D-HRM suggèrent qu'il s'agit d'un nouvel outil prometteur pour l'étude de la physiopathologie du RGO. Au cours de la déglutition, nous avons évalué la faisabilité d’améliorer la mesure de l’IRP en utilisant ce nouveau cathéter de manométrie 3D avec un nouveau paradigme (3D eSleeve) basé sur l’utilisation de la pression radiale minimale à chaque niveau de capteurs de pression. Nos résultats suggèrent que cette approche est plus précise que celle de la manométrie haute résolution standard. La 3D-HRM devrait certainement améliorer la précision des mesures de relaxation de la JOG et cela devrait avoir un impact sur la recherche pour modéliser la JOG au cours de la déglutition et dans le RGO. / Background & Aims: Conventional water-perfused manometry and high resolution manometry permitted the development of a variety of manometric methodologies and metrics to understand the motility of the esophagus and to quantify esophagogastric junction (EGJ) characteristics. However, the anatomy in the area of the EGJ is complex and intraluminal manometry recordings detect pressure signals referable both to intrinsic esophageal structures and to adjacent extrinsic structures impinging on the esophagus. Both have distinct sphincteric mechanisms within the EGJ. The dominant pressure signals detected near the EGJ are attributable to the lower esophageal sphincter (LES) and the crural diaphragm (CD). However, neither of these technologies were able to distinguish between the different components of the EGJ. When analyzing EGJ characteristics as a reflection of its competence against reflux, the more widely used manometric parameters are the EGJ length and the respiratory inversion point (RIP), defined as the location at which inspiratory pressure deflections change from positive (abdomen) to negative (chest). However, the significance of these metrics has not gained wide acceptance in the gastroenterology community as evident in a recent American Gastroenterology Association Institute (AGAI) Position Statement (1) concluding that ‘The current role of manometry in gastroesophageal reflux disease (GERD) is to exclude motor disorders as a cause of the continued symptoms’. During deglutition, the objective quantitative measurement of EGJ relaxation, the integrative relaxation pressure (IRP), permits one to distinguish between normal and abnormal EGJ relaxation. However, comparison between spatial pressure variation plots and relaxation pressures derived from circumferentially averaged pressures suggest a persistent high pressure at the hiatal center during a period that flow is known to be occurring whereas this was not seen using nadir radial pressure data. Recently, a 3D-high resolution manometry (3D-HRM) assembly (Given Imaging, Duluth, GA) has been developed with the potential to simplify the assessment of EGJ pressure morphology and physiology. The 3D segment of the array permits high resolution recording both axially and radially while maintaining a stationary sensor position. Consequently, 3D-HRM should allow for the measurement of important EGJ parameters such as length and RIP. Data extracted from the 3D-HRM recording may also allow differentiating pressure signals within the EGJ attributable to the intrinsic sphincter and to the surrounding elements. Moreover, 3D-HRM preserves the individual pressure values of each radially dispersed sensor within the array, permitting one to overcome the apparent persistent high pressure during the deglutitive relaxation. Thus, the aims of this work were 1) to describe the EGJ pressure morphology at rest, comparing measures made with real time 3D-HRM to simulations of a conventional pull-through protocol and to define the pressure signatures attributable to the diaphragmatic and LES pressure components within the 3D-HRM recording; 2) to assess deglutitive EGJ relaxation by testing the hypothesis that the 3D-HRM array using an analysis paradigm based on finding the minimal radial pressure at each axial level (3D-eSleeve) should provide a representation of the luminal pressure gradient across the EGJ that is more relevant to predicting periods of trans-sphincteric flow using barium transit on fluoroscopy as the comparator. We also sought to adapt the IRP metric to the 3D-HRM array using the 3D-eSleeve principle (3D-IRP) and compare normative values obtained with this new paradigm to standard IRP calculations. Methods: Patients were studied with a 3D-HRM assembly. The 3D-HRM assembly incorporated a 9 cm 3D-HRM segment into an otherwise standard HRM assembly; the 3D segment was comprised of 12 rings of 8 radially dispersed independent pressure sensors, spaced 7.5mm apart. At rest, 9 volunteers were studied and recordings were done during a station pull-through of the 3D-HRM segment withdrawing it across the EGJ at 5 mm increments with each position held for 30s (sufficient to capture several respiratory cycles). Conventional measures of ‘LES length’ were made using 4 radially dispersed sensors within the 3D-HRM array, defining the margins of the sphincter by a 2 mmHg pressure increase relative to gastric or esophageal pressure. In the 3D-HRM, the proximal and distal limits of the EGJ were defined as the axial locations first detecting a 360° circumferential pressure increase of 2 mmHg relative to the stomach. RIP was determined, A) in the tracing mode: using the pull-through of 4 single sensors spaced 7.5 mm apart [RIP is the average value of 4 radially dispersed sensors] and B) in a stationary position using the software pressure inversion point (PIP) tool. In the esophageal pressure topography (EPT) mode, the tracing changed progressively from a thoracic pattern to an abdominal pattern, and the RIP was localized within the inversion zone with the PIP tool tracing. For the study of the EGJ deglutitive relaxation, 25 volunteers underwent 3 consecutive 10-swallows protocols of 5 ml of water in the supine position with both the standard (once) and 3D-HRM (twice) devices in random sequence. During the 3D-HRM studies, the EGJ was measured once with the 3D-sleeve segment and once with a proximal (non-3D sleeve portion) of the device incorporating standard HRM sensors. For each subject, the IRP was calculated in four ways: 1) conventional method with the standard HRM device, 2) conventional method with a standard HRM segment of the 3D-HRM device, 3) conventional method using the 3D-HRM sleeve segment, and 4) a novel 3D-HRM eSleeve paradigm (3D-IRP) localizing the radial pressure minimum at each locus along the eSleeve. Fourteen additional subjects then underwent synchronized simultaneous videofluoroscopy and 3D-HRM (including two 5-ml barium swallows). Pressure data were exported to MATLAB™ and four pressures were measured simultaneously: 1) esophageal body pressure 2cm above EGJ, 2) intragastric pressure, 3) radially average eSleeve pressure and 4) 3D-eSleeve pressure. Data were plotted to determine the flow permissive time (FPT) characterized as periods during which a pressure gradient through the EGJ is present (esophageal pressure > EGJ relaxation pressure (radial average or 3D-eSleeve paradigm) > gastric pressure). FPT was calculated during a 10s time window after upper sphincter relaxation. The presence or absence of bolus transit or FPT was coded with dichotomous values for each 0.1 s. We calculated the corresponding sensitivity and specificity for both radial average and 3D-eSleeve analyses of FPT with bolus transit evident on fluoroscopy being the reference. Results: 3D-HRM recordings suggested that sphincter length assessed by a pull-through method greatly exaggerated the estimate of LES length by failing to discriminate among circumferential contractile pressure and asymmetric extrinsic pressure signals attributable to diaphragmatic and vascular structures. Real-time 3D EGJ recordings found that the dominant constituents of EGJ pressure at rest were attributable to the diaphragm. The 3D-IRP was significantly less than all other calculations of IRP with the upper limit of normal being 12 mmHg vs. 17 mmHg for the standard IRP. The sensitivity (0.78) and the specificity (0.88) of the 3D-eSleeve were also better than the standard eSleeve (0.55 and 0.85, respectively) for predicting flow permissive time verified fluoroscopically. Discussion & Conclusion: Our observations suggest that the 3D-HRM permits real-time recording of EGJ pressure morphology facilitating analysis of the EGJ constituents responsible for its function as a reflux barrier at rest. The axial and radial spatial resolution of the 9 cm 3D-HRM segment may permit further studies to differentiate pressure signals within the EGJ attributable to the LES and to extrinsic structures (diaphragm and vascular artifacts). These attributes of the 3D-HRM device suggest it to be a promising new tool in the study of GERD pathophysiology. During deglutition, we evaluated the feasibility of improving the measurement of IRP utilizing a novel 3D-HRM assembly and a novel 3D-eSleeve concept based on finding the axial maximum of the radial minimum pressures at each sensor ring along the sleeve segment. Our findings suggest that this approach is more accurate than standard HRM and other methods that utilize a radially averaged pressure within the EGJ. Although we can only speculate on how much this will improve clinical management, 3D-HRM will certainly improve the accuracy of EGJ relaxation measurements and this will certainly impact research endeavors focused on modeling EGJ function during swallowing and reflux.

O tratamento cirúrgico do adenocarcinoma da junção esofagogástrica (AJEG) ainda é controverso, particularmente, em relação à sobrevida e complicações pós-operatórias. Com o advento da cirurgia minimamente invasiva e toracoscopia, houve um aumento da linfadenectomia e menores complicações, entretanto seu impacto na sobrevida do AEGJ é pouco conhecido. Objetivos: Comparar a esofagectomia por via transtorácica por toracoscopia (grupo A) com esofagectomia por via transhiatal (grupo B) em pacientes com AJEG em relação a ocorrência de complicações e mortalidade; número de linfonodos ressecados, acometidos e relação ressecados e acometidos; sobrevidas global e livre de doença; e sobrevida após recidiva. Métodos: Foram selecionados 147 pacientes entre 2000 e 2016. Cento e trinta (88%) do sexo masculino, média de idade de 64 anos. Os dados epidemiológicos (idade, sexo, índice de massa corpórea, ECOG e antecedentes pessoais) foram avaliados e comparados entre os grupos. As complicações pós-operatórias (fistula cervical, quilotorax, complicações respiratórias, rouquidão e infecções cirúrgicas) foram avaliadas. O estadiamento anátomo-patológico foi avaliado pela 7a. edição AJCC, analisando os linfonodos ressecados, acometidos e a relação de ressecados e acometidos. Foram feitas análises da sobrevivência global, livre de doença, e após recidiva; além de análise multivariada de fatores relacionados à sobrevida. Resultados: Em relação aos dados epidemiológicos, o grupo A apresentava uma média de idade de 61,1 anos e grupo B, de 65,7 anos (p=0,009). Dos 54 pacientes do grupo A, 47 (87,0%) foram submetidos a tratamento neoadjuvante, contra 43 (46,3%) dos 93 pacientes do grupo B (p < 0,001). Em relação às complicações, o grupo A apresentou maior ocorrência de rouquidão e infecções cirúrgicas. Em relação à mortalidade, o grupo A apresentou dois casos (3,7%) e grupo B apresentou quatro (4,3%), sem diferença estatística. Não houve diferença estatística entre os grupos A e B quanto à localização topográfica do tumor, grau histológico, pT, pN, estádio, extensão do tumor, invasão linfática, venosa e perineural. No grupo A, a média de linfonodos ressecados foi 31,88 linfonodos e no grupo B 20,73 linfonodos (p < 0,001); entretanto a média de linfonodos acometidos no grupo A foi 3,96 linfonodos e no grupo B 4,25 linfonodos, sem diferença estatística, bem como a razão ressecados acometidos. A sobrevida global geral foi 42,3%, nos grupo A, 38,9% e no grupo B, 7,6% (p=0,298). Na análise multivariada da sobrevida global somente a invasão linfática (p=0,005), diabetes mellitus (p=0,038) e infecção cirúrgica (p=0,001) foram significantes. A sobrevida livre de doença geral foi 45,6%, no grupo A 40% e grupo B 46% (p=0,77) e, na multivariada, somente a invasão linfática (p=0,01) e o diabetes mellitus (p=0,049) foram significantes. Entretanto nos tumores com estádio até 2B a sobrevida global do grupo A foi 80,4% e do grupo B, 38,5% (p=0,001). A sobrevida após recidiva foi melhor na recidiva pulmonar, seguida pela hepática ou mediastinal e peritoneal (p=0,001). Conclusão: Ambos os métodos são seguros com taxas de morbidade e mortalidade semelhantes. A esofagectomia por toracoscopia permite uma ressecção maior do número de linfonodos. As sobrevidas globais e livres de doença são semelhantes, entretanto até o estádio 2B a esofagectomia por toracoscopia melhora a sobrevida global. Diabetes e invasão linfática interferem na sobrevida global e livre de doença / The surgical treatment of adenocarcinoma of the esophagogastric junction surgical treatment (AGEJ) is still controversial, particularly concerning to survival and postoperative complications. With the advent of minimally invasive surgery and thoracoscopy, there has been an increase in lymphadenectomy and less complications, however its impact on survival of AGEJ is still unknown. Objectives: To compare transthoracic thoracoscopic esophagectomy (group A) with transhiatal esophagectomy (group B) in patients with AGEJ in relation to the occurrence of complications and mortality; number of ressected lymph nodes, the positive and the ratio between the ressected and positive; overall and disease free survival; and survival after relapse. Methods: There was a selection of 147 patients from 2000 to 2016. One hundred and thirty (88%) were male, the average age was 64 years old. Epidemiological data (age, sex, body mass index, ECOG and past medical history) were analyzed and compared between the groups. Postoperative complications (cervical fistulae, chylothorax, respiratory complications, hoarseness and surgical infections) were evaluated. The anatomopathological staging was evaluated by the 7th UICC edition, analyzing the resected lymph nodes, the affected and the ratio between the resected and affected. Analysis of overall survival, disease free survival and survival after relapse were made, besides multivariate analysis of survival related factors. Results: In relation to the epidemiological data, group A presented an average age of 61.1 years, and group B of 65.7 years (p=0.009). 47 (87.0%) of the 54 patients in group A were submitted to neoadjuvant treatments, against 43 (46.3%) of the 93 patients in group B (p < 0.001). In relation to the complications, group A presented greater occurrence of hoarseness and surgical infections. In relation to mortality, group A presented 2 cases (3.7%) and group B presented 4 (4.3%), without statistical difference. There was no statistical difference between groups A and B about topographic location of the tumor, histologic grade, pT, pN, stage, tumor extension, lymphatic, venous or perineural invasion. In group A, the average number of ressected lymph nodes was 31.88 and in group B was 20.73 (p < 0.001), however the average number of affected lymph nodes was 3.96 in group A and 4.25 in group B, without statistical difference, as well as the ratio between ressected and affected lymph nodes. The general overall survival was 42.3%, in group A was 38.9% and in group B was 47.6% (p=0.298). In the multivariate analysis of overall survival only lymphatic invasion (p=0.005), diabetes mellitus (p=0.038) and surgical infection (p- 0.001) were significant. The general disease free survival was 45.6%, in group A was 40% and in group B was 46% (p=0.77) and in multivariate analysis only lymphatic invasion (p=0.01) and diabetes mellitus (p=0.049) were significant. However, in tumors with stage until 2B, group A overall survival was 80.4% and group B was 38.5% (p=0.001). Survival after relapse was better in pulmonary relapse, followed by hepatic or mediastinal and peritoneal (p=0.001). Conclusion: Both methods are safe with similar morbidity and mortality rates. Transthoracic thoracoscopic esophagectomy allows a larger ressection in the number of lymph nodes. Overall survival and disease free survival are similar, however until stage 2B thoracoscopic esophagectomy improves overall survival. Diabetes and lymphatic invasion interfere in overall and disease free survival

Made available in DSpace on 2015-07-22T20:49:26Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-09-30. Added 1 bitstream(s) on 2015-08-11T03:25:59Z : No. of bitstreams: 1 Publico-11859a.pdf: 1971801 bytes, checksum: dc22083567fcbecdefe8d1bc1ef866e9 (MD5). Added 1 bitstream(s) on 2015-08-11T03:25:59Z : No. of bitstreams: 2 Publico-11859a.pdf: 1971801 bytes, checksum: dc22083567fcbecdefe8d1bc1ef866e9 (MD5) Publico-11859b.pdf: 1464854 bytes, checksum: ed8fffe60a11710f362faadbbbf6b037 (MD5). Added 1 bitstream(s) on 2015-08-11T03:25:59Z : No. of bitstreams: 3 Publico-11859a.pdf: 1971801 bytes, checksum: dc22083567fcbecdefe8d1bc1ef866e9 (MD5) Publico-11859b.pdf: 1464854 bytes, checksum: ed8fffe60a11710f362faadbbbf6b037 (MD5) Publico-11859c.pdf: 618900 bytes, checksum: ce78a0221e4d7c2792bf114602ddb45d (MD5). Added 1 bitstream(s) on 2015-08-11T03:25:59Z : No. of bitstreams: 4 Publico-11859a.pdf: 1971801 bytes, checksum: dc22083567fcbecdefe8d1bc1ef866e9 (MD5) Publico-11859b.pdf: 1464854 bytes, checksum: ed8fffe60a11710f362faadbbbf6b037 (MD5) Publico-11859c.pdf: 618900 bytes, checksum: ce78a0221e4d7c2792bf114602ddb45d (MD5) Publico-11859d.pdf: 1753706 bytes, checksum: 1aa5162c1f98a814fc5f261944e41f5a (MD5) / Desenho do estudo: Transversal, não experimental. Objetivos: Detectar e comparar as alterações funcionais esofágicas e da junção esôfago-gástrica em dois grupos de pacientes com lesão medular crônica, um no nível da inervação frênica e o outro em níveis torácicos superiores, e relacioná-las à contenção do refluxo gastroesofágico. Sumário e contexto: Em lesados medulares não há estudo manométrico esofágico associado à pHmetria. A estatística mundial revela que a prevalência de doença do refluxo gastroesofágico em lesados medulares é maior que a população geral, em torno de 22 a 27%. A "crura diafragmática" vem sendo reconhecida como importante barreira antirefluxo e, funcionalmente, deveria ser considerada como um músculo separado do diafragma costal, mas permanece a dúvida se essa diferença está relacionada com sua inervação. Métodos: O estudo é transversal em que participaram 29 pacientes com lesão medular completa, sendo 14 tetraplégicos (nível C4) e 15 paraplégicos (níveis T1 a T7). As alterações funcionais da junção esôfagogástrica, esôfago e diafragma foram avaliadas através da manometria esofágica e vídeo-fluoroscopia diafragmática; presença de refluxo gastroesofágico por dados subjetivos (pirose e regurgitação) e objetivos (dados pHmétricos e endoscópicos). Resultados: A prevalência da doença do refluxo gastroesofágico foi de 27,6%, sem diferença entre os grupos. Esta foi estatisticamente significante quando se comparou as médias da pressão da crura diafragmática (tetraplégico: 37,5&#61617;17,8; paraplégico: 26,6&#61617;7,2; p=0,048). Também teve significância em relação à prevalência de no mínimo um dos achados objetivos e/ou subjetivos de refluxo e/ou do peristaltismo esofágico (tetraplégico: 85,7%; paraplégico: 40%; p=0,011). Conclusões: A lesão medular no nível da inervação frênica não predispôs os tetraplégicos a um risco maior para desenvolver a doença do refluxo gastroesofágico. Paradoxalmente, a manometria mostrou uma contractilidade da crura diafragmática significantemente maior nos tetraplégicos. / Study design: Cross-sectional and non-experimental. Objective: To detect and compare functional abnormalities in the esophagus and esophagogastric junction in two groups with chronic spinal injuries, one with injuries at the phrenic innervation level and the other at upper thoracic levels, and to relate these to gastroesophageal reflux containment. Summary of background data: There are no studies on esophageal manometry with pH metering among spinal cord injury patients. Worldwide statistics reveal that the prevalence of gastroesophageal reflux disease among spinal cord injury patients is greater than among the general population, at around 22 to 27%. The "diaphragmatic crura" has been recognized as an important antireflux barrier and should functionally be considered to be a muscle separated from the costal diaphragm. However, doubts remain regarding whether this difference relates to its innervation. Methods: This was a cross-sectional study on 29 patients with complete spinal cord injuries: 14 quadriplegics (level C4) and 15 paraplegics (levels T1 to T7). Functional abnormalities of the esophagogastric junction, esophagus and diaphragm were investigated using esophageal manometry and diaphragmatic video fluoroscopy. Presence of gastroesophageal reflux was investigated subjectively (pyrosis and regurgitation) and objectively (pH metering and endoscopy). Results: The prevalence of gastroesophageal reflux disease was 27.6%, without difference between the groups. This became statistically significant when the mean diaphragmatic crura pressures were compared (quadriplegics: 37.5 &#61617; 17.8; paraplegics: 26.6 &#61617; 7.2; p=0.048). It was also significant in relation to the prevalence of at least one of the objective and/or subjective reflux findings and/or esophageal peristaltism (quadriplegics: 85.7%; paraplegics: 40%; p=0.011). Conclusions: Spinal injury at the level of the phrenic innervation did not predispose the quadriplegics towards greater risk of developing gastroesophageal reflux disease. Paradoxically, manometry showed significantly greater crura contractility among the quadriplegics. / TEDE / BV UNIFESP: Teses e dissertações

Key words: adenocarcinoma of the esophagus and esophagogastric junction, neoadjuvant chemotherapy, PET/CT, histopathological response, technique of esophagogastric anastomosis, anastomotic leak, anastomotic stricture Previous studies have shown that preoperative chemotherapy of locally advanced AEG is beneficial only for patients with a good histopathological response, the so-called responders. The aim of the first part of the thesis was to prospectively verify whether positron emission tomography (PET/CT) could be used for early identification of histopathological non- responders, who could be spared ineffective neoadjuvant treatment. Our study did not prove that the early metabolic response, expressed as the percentage change of the consumption of glucosis on PET/CT performed before (PET1) and 12 to 22 days after the start of the first cycle of preoperative chemotherapy (PET2) correlated with the histopathological response in the resection specimen in the entire population of 90 patients. In a post hoc explorative analysis we found the correlation between metabolic and histopathological response in a subgroup of patients with PET2 performed ≤16 days after the start of the therapy, but this hypothesis needs to be prospectively validated. Our study suggests that PET/CT performed after the first...

O tratamento cirúrgico do adenocarcinoma da junção esofagogástrica (AJEG) ainda é controverso, particularmente, em relação à sobrevida e complicações pós-operatórias. Com o advento da cirurgia minimamente invasiva e toracoscopia, houve um aumento da linfadenectomia e menores complicações, entretanto seu impacto na sobrevida do AEGJ é pouco conhecido. Objetivos: Comparar a esofagectomia por via transtorácica por toracoscopia (grupo A) com esofagectomia por via transhiatal (grupo B) em pacientes com AJEG em relação a ocorrência de complicações e mortalidade; número de linfonodos ressecados, acometidos e relação ressecados e acometidos; sobrevidas global e livre de doença; e sobrevida após recidiva. Métodos: Foram selecionados 147 pacientes entre 2000 e 2016. Cento e trinta (88%) do sexo masculino, média de idade de 64 anos. Os dados epidemiológicos (idade, sexo, índice de massa corpórea, ECOG e antecedentes pessoais) foram avaliados e comparados entre os grupos. As complicações pós-operatórias (fistula cervical, quilotorax, complicações respiratórias, rouquidão e infecções cirúrgicas) foram avaliadas. O estadiamento anátomo-patológico foi avaliado pela 7a. edição AJCC, analisando os linfonodos ressecados, acometidos e a relação de ressecados e acometidos. Foram feitas análises da sobrevivência global, livre de doença, e após recidiva; além de análise multivariada de fatores relacionados à sobrevida. Resultados: Em relação aos dados epidemiológicos, o grupo A apresentava uma média de idade de 61,1 anos e grupo B, de 65,7 anos (p=0,009). Dos 54 pacientes do grupo A, 47 (87,0%) foram submetidos a tratamento neoadjuvante, contra 43 (46,3%) dos 93 pacientes do grupo B (p < 0,001). Em relação às complicações, o grupo A apresentou maior ocorrência de rouquidão e infecções cirúrgicas. Em relação à mortalidade, o grupo A apresentou dois casos (3,7%) e grupo B apresentou quatro (4,3%), sem diferença estatística. Não houve diferença estatística entre os grupos A e B quanto à localização topográfica do tumor, grau histológico, pT, pN, estádio, extensão do tumor, invasão linfática, venosa e perineural. No grupo A, a média de linfonodos ressecados foi 31,88 linfonodos e no grupo B 20,73 linfonodos (p < 0,001); entretanto a média de linfonodos acometidos no grupo A foi 3,96 linfonodos e no grupo B 4,25 linfonodos, sem diferença estatística, bem como a razão ressecados acometidos. A sobrevida global geral foi 42,3%, nos grupo A, 38,9% e no grupo B, 7,6% (p=0,298). Na análise multivariada da sobrevida global somente a invasão linfática (p=0,005), diabetes mellitus (p=0,038) e infecção cirúrgica (p=0,001) foram significantes. A sobrevida livre de doença geral foi 45,6%, no grupo A 40% e grupo B 46% (p=0,77) e, na multivariada, somente a invasão linfática (p=0,01) e o diabetes mellitus (p=0,049) foram significantes. Entretanto nos tumores com estádio até 2B a sobrevida global do grupo A foi 80,4% e do grupo B, 38,5% (p=0,001). A sobrevida após recidiva foi melhor na recidiva pulmonar, seguida pela hepática ou mediastinal e peritoneal (p=0,001). Conclusão: Ambos os métodos são seguros com taxas de morbidade e mortalidade semelhantes. A esofagectomia por toracoscopia permite uma ressecção maior do número de linfonodos. As sobrevidas globais e livres de doença são semelhantes, entretanto até o estádio 2B a esofagectomia por toracoscopia melhora a sobrevida global. Diabetes e invasão linfática interferem na sobrevida global e livre de doença / The surgical treatment of adenocarcinoma of the esophagogastric junction surgical treatment (AGEJ) is still controversial, particularly concerning to survival and postoperative complications. With the advent of minimally invasive surgery and thoracoscopy, there has been an increase in lymphadenectomy and less complications, however its impact on survival of AGEJ is still unknown. Objectives: To compare transthoracic thoracoscopic esophagectomy (group A) with transhiatal esophagectomy (group B) in patients with AGEJ in relation to the occurrence of complications and mortality; number of ressected lymph nodes, the positive and the ratio between the ressected and positive; overall and disease free survival; and survival after relapse. Methods: There was a selection of 147 patients from 2000 to 2016. One hundred and thirty (88%) were male, the average age was 64 years old. Epidemiological data (age, sex, body mass index, ECOG and past medical history) were analyzed and compared between the groups. Postoperative complications (cervical fistulae, chylothorax, respiratory complications, hoarseness and surgical infections) were evaluated. The anatomopathological staging was evaluated by the 7th UICC edition, analyzing the resected lymph nodes, the affected and the ratio between the resected and affected. Analysis of overall survival, disease free survival and survival after relapse were made, besides multivariate analysis of survival related factors. Results: In relation to the epidemiological data, group A presented an average age of 61.1 years, and group B of 65.7 years (p=0.009). 47 (87.0%) of the 54 patients in group A were submitted to neoadjuvant treatments, against 43 (46.3%) of the 93 patients in group B (p < 0.001). In relation to the complications, group A presented greater occurrence of hoarseness and surgical infections. In relation to mortality, group A presented 2 cases (3.7%) and group B presented 4 (4.3%), without statistical difference. There was no statistical difference between groups A and B about topographic location of the tumor, histologic grade, pT, pN, stage, tumor extension, lymphatic, venous or perineural invasion. In group A, the average number of ressected lymph nodes was 31.88 and in group B was 20.73 (p < 0.001), however the average number of affected lymph nodes was 3.96 in group A and 4.25 in group B, without statistical difference, as well as the ratio between ressected and affected lymph nodes. The general overall survival was 42.3%, in group A was 38.9% and in group B was 47.6% (p=0.298). In the multivariate analysis of overall survival only lymphatic invasion (p=0.005), diabetes mellitus (p=0.038) and surgical infection (p- 0.001) were significant. The general disease free survival was 45.6%, in group A was 40% and in group B was 46% (p=0.77) and in multivariate analysis only lymphatic invasion (p=0.01) and diabetes mellitus (p=0.049) were significant. However, in tumors with stage until 2B, group A overall survival was 80.4% and group B was 38.5% (p=0.001). Survival after relapse was better in pulmonary relapse, followed by hepatic or mediastinal and peritoneal (p=0.001). Conclusion: Both methods are safe with similar morbidity and mortality rates. Transthoracic thoracoscopic esophagectomy allows a larger ressection in the number of lymph nodes. Overall survival and disease free survival are similar, however until stage 2B thoracoscopic esophagectomy improves overall survival. Diabetes and lymphatic invasion interfere in overall and disease free survival